Nonadherence to immune-modifying therapies during the COVID-19 pandemic: the crucial role of doctor-patient communication in avoiding drug discontinuation.
The British journal of dermatology(2023)
Abstract
Journal Article Nonadherence to immune-modifying therapies during the COVID-19 pandemic: the crucial role of doctor–patient communication in avoiding drug discontinuation Get access Mario Valenti, Mario Valenti Department of Biomedical Sciences, Humanitas University, Pieve Emanuele, ItalyDermatology Unit, IRCCS Humanitas Research Hospital, Rozzano, Italy Search for other works by this author on: Oxford Academic Google Scholar Antonio Costanzo Antonio Costanzo Department of Biomedical Sciences, Humanitas University, Pieve Emanuele, ItalyDermatology Unit, IRCCS Humanitas Research Hospital, Rozzano, Italy Correspondence: Antonio Costanzo. Email: antonio.costanzo@hunimed.eu Search for other works by this author on: Oxford Academic Google Scholar British Journal of Dermatology, Volume 188, Issue 5, May 2023, Pages 586–590, https://doi.org/10.1093/bjd/ljad014 Published: 19 January 2023 Article history Received: 13 January 2023 Published: 19 January 2023 Corrected and typeset: 14 February 2023 Accepted: 23 February 2023
MoreTranslated text
Key words
doctor–patient communication,therapies,immune-modifying
AI Read Science
Must-Reading Tree
Example
![](https://originalfileserver.aminer.cn/sys/aminer/pubs/mrt_preview.jpeg)
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined